Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecht Olsen

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
British Journal of Sports Medicine|November 30, 2022
Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Emil Eik Nielsen, Tara Ballav Adhikari, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 27, 2021
Clinical audit of adherence to hypertension treatment guideline and control rates in hospitals of different sizes in ThailandChaisiri Angkurawaranon, Kanokporn Pinyopornpanish, Supattra Srivanichakorn, et al.
Atherosclerosis|September 16, 2014
Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjectsMette Hjortdal Sørensen, Oke Gerke, Jesper Eugen-Olsen, et al.
Journal of Human Hypertension|March 22, 2022
Perceptions of pharmacists on the quality of automated blood pressure devices: a national surveyDean S Picone, Gregory M Peterson, Shane L Jackson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 30, 2020
Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)Maria Lukács Krogager, Manan Pareek, Kristian Hay Kragholm, et al.
Blood Pressure|September 25, 2016
Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiographySøren Sandager Petersen, Line Reinholdt Pedersen, Manan Pareek, et al.
Journal of Human Hypertension|March 24, 2022
Emerging Authors Program for Global Cardiovascular Disease Research-A collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Bethany Hall, Qaiser Mukhtar, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
Identification of Important Factors Affecting Use of Digital Individualised Coaching and Treatment of Type 2 Diabetes in General Practice: A Qualitative Feasibility StudyPernille Ravn Jakobsen, Jeanette Reffstrup Christensen, Jesper Bo Nielsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2021
Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Christina Byrne, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 28, 2020
Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention TrialJohanna Maria Christina Frary, Manan Pareek, Christina Byrne, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
British Journal of Sports Medicine|November 30, 2022
Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Emil Eik Nielsen, Tara Ballav Adhikari, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 27, 2021
Clinical audit of adherence to hypertension treatment guideline and control rates in hospitals of different sizes in ThailandChaisiri Angkurawaranon, Kanokporn Pinyopornpanish, Supattra Srivanichakorn, et al.
Atherosclerosis|September 16, 2014
Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjectsMette Hjortdal Sørensen, Oke Gerke, Jesper Eugen-Olsen, et al.
Journal of Human Hypertension|March 22, 2022
Perceptions of pharmacists on the quality of automated blood pressure devices: a national surveyDean S Picone, Gregory M Peterson, Shane L Jackson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 30, 2020
Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)Maria Lukács Krogager, Manan Pareek, Kristian Hay Kragholm, et al.
Blood Pressure|September 25, 2016
Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiographySøren Sandager Petersen, Line Reinholdt Pedersen, Manan Pareek, et al.
Journal of Human Hypertension|March 24, 2022
Emerging Authors Program for Global Cardiovascular Disease Research-A collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Bethany Hall, Qaiser Mukhtar, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
Identification of Important Factors Affecting Use of Digital Individualised Coaching and Treatment of Type 2 Diabetes in General Practice: A Qualitative Feasibility StudyPernille Ravn Jakobsen, Jeanette Reffstrup Christensen, Jesper Bo Nielsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2021
Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Christina Byrne, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 28, 2020
Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention TrialJohanna Maria Christina Frary, Manan Pareek, Christina Byrne, et al.
Pageof 13